Medtech stocks hurt by overall market slide
The five Singapore-listed stocks that are part of the industry have generated an average one-year total return of minus 10%
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
THE medtech industry, as represented by the listed stocks on the Singapore Exchange (SGX), has been hurt by market volatility despite the bubbling prospects of the sector.
The five Singapore-listed stocks that are part of the healthcare equipment and supplies industry, which now include the latest medtech listing Biolidics have generated an average one-year total return of negative 10 per cent. This, however, is in line with the total one-year return of about negative 10.5 per cent of the Straits Times Index, data from Bloomberg showed.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
